乳腺癌药物市场。 - Suppr

Suppr

超能文献

The breast cancer drug market.

作者信息

Wilcock Paul, Webster Rachel M

出版信息

Nat Rev Drug Discov. 2021 May;20(5):339-340. doi: 10.1038/d41573-021-00018-6.

DOI:10.1038/d41573-021-00018-6

PMID:33483705

Abstract

摘要

相似文献

The breast cancer drug market.

Nat Rev Drug Discov. 2021 May;20(5):339-340. doi: 10.1038/d41573-021-00018-6.

The breast cancer market.

Nat Rev Drug Discov. 2015 Apr;14(4):233-4. doi: 10.1038/nrd4571.

The bladder cancer drug market.

Nat Rev Drug Discov. 2016 Sep;15(9):599-600. doi: 10.1038/nrd.2016.141. Epub 2016 Aug 5.

Cost utility of sequential adjuvant trastuzumab for HER2/Neu-positive breast cancer.

Value Health. 2009 Jul-Aug;12(5):637-40. doi: 10.1111/j.1524-4733.2009.00564.x. Epub 2009 May 15.

Market watch: Upcoming catalysts in Q1 2015.

Nat Rev Drug Discov. 2015 Jan;14(1):9. doi: 10.1038/nrd4517. Epub 2014 Dec 12.

Market watch: upcoming market catalysts in Q4 2012.

Nat Rev Drug Discov. 2012 Oct;11(10):740. doi: 10.1038/nrd3856.

Charging what the market will bear is inappropriate.

Clin Adv Hematol Oncol. 2014 Jan;12(1):63.

Optimal adjuvant chemotherapy in breast cancer: selection of agents.

Expert Rev Clin Pharmacol. 2014 Sep;7(5):605-11. doi: 10.1586/17512433.2014.945429. Epub 2014 Aug 1.

Expert Opin Ther Pat. 2014 Nov;24(11):1149-53. doi: 10.1517/13543776.2014.964683. Epub 2014 Oct 11.

[Position statement of the (Hungarian) College of Oncology and Radiotherapy regarding the financing of Tyverb (lapatinib) based on individual discretionary compassionate care].

Magy Onkol. 2009 Mar;53(1):77-9. doi: 10.1556/MOnkol.53.2009.1.11.

引用本文的文献

Targeting Reticulin 4 (RTN4) Within Small Extracellular Vesicles Combats Metastasis and Reinforces Immunotherapy in Triple-Negative Breast Cancer.

J Extracell Vesicles. 2025 Aug;14(8):e70154. doi: 10.1002/jev2.70154.

Artificial intelligence-assisted RNA-binding protein signature for prognostic stratification and therapeutic guidance in breast cancer.

Front Immunol. 2025 Apr 16;16:1583103. doi: 10.3389/fimmu.2025.1583103. eCollection 2025.

Comprehensive analysis of breast cancer oxidative stress related gene signature: a combination of bulk and single-cell RNA sequencing analysis.

Mamm Genome. 2025 Apr 24. doi: 10.1007/s00335-025-10130-2.

Neuropilin-1-target self-assembled peptide nanoparticles contribute to tumor treatment by inducing pyroptosis.

BMC Cancer. 2025 Mar 6;25(1):413. doi: 10.1186/s12885-025-13784-y.

Interlaboratory variability of HER2 fluorescence in situ hybridization testing in breast cancer: results of a multicenter proficiency-testing ring study in China.

Diagn Pathol. 2024 Dec 20;19(1):161. doi: 10.1186/s13000-024-01588-w.

Integration of Machine Learning and Experimental Validation to Identify Anoikis-Related Prognostic Signature for Predicting the Breast Cancer Tumor Microenvironment and Treatment Response.

Genes (Basel). 2024 Nov 12;15(11):1458. doi: 10.3390/genes15111458.

Deciphering breast cancer dynamics: insights from single-cell and spatial profiling in the multi-omics era.

Biomark Res. 2024 Sep 18;12(1):107. doi: 10.1186/s40364-024-00654-1.

Comparative analysis of adverse events associated with CDK4/6 inhibitors based on FDA's adverse event reporting system: a case control pharmacovigilance study.

BMC Pharmacol Toxicol. 2024 Aug 9;25(1):47. doi: 10.1186/s40360-024-00770-6.

Grand Challenges in Molecular Medicine for Disease Prevention and Treatment Through Cyclical Innovation.

Front Mol Med. 2021 Jul 15;1:720577. doi: 10.3389/fmmed.2021.720577. eCollection 2021.

Targeting estrogen mediated CYP4F2/CYP4F11-20-HETE metabolic disorder decelerates tumorigenesis in ER+ breast cancer.

Biochem Biophys Rep. 2024 Apr 12;38:101706. doi: 10.1016/j.bbrep.2024.101706. eCollection 2024 Jul.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验